Targeting CV risk factors with GLP-1 RAs in people with obesity

Novo Nordisk A/S |

Chair: Michael Lincoff (USA)

18:00 – 18:05Welcome and introductionMichael Lincoff (USA)
18:05 – 18:15CV risk: What’s weight got to do with it?John Deanfield (UK)
18:15 – 18:25Improvements in CV risk factors: STEP by STEPBenjamin M. Scirica (USA)
18:25 – 18:35SELECT and STEP-HFpEF: New horizonsMichael Lincoff (USA)
18:35 – 18:55Panel discussionAll speakers
18:55 – 19:00ClosingMichael Lincoff (USA)